M.D. Anderson Cancer Center

SEP 9, 2026 · PHASE 1/2 TRIAL

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

ClinicalTrials.gov

This is a Phase 1/2 trial registration with no posted results; the study is active but not yet recruiting and outcome data are not available.

SEP 4, 2026 · INTERVENTIONAL STUDY

A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE)

ClinicalTrials.gov

This is an active, single-arm registry study with no posted results; it aims to assess safety and quality of life in a small, single-center population but cannot yet support any clinical claim.

SEP 4, 2026 · PHASE 1 TRIAL

mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian

ClinicalTrials.gov

Phase 1b/II dose-escalation trial with planned enrollment and no results yet reported in this registry record; early-phase design focused on safety and maximum tolerated dose.

AUG 18, 2026 · PHASE 1/2 TRIAL

NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer

ClinicalTrials.gov

Phase 1/2 single-arm registry record with no posted results; describes a planned study in early-stage development for a novel nanoparticle therapy in lung cancer.

AUG 14, 2026 · INTERVENTIONAL STUDY

Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer

ClinicalTrials.gov

A feasibility study with no posted results assessing exercise adherence and retention in older women with breast cancer during chemotherapy; designed to test implementation rather than clinical efficacy.

AUG 12, 2026 · INTERVENTIONAL STUDY

Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer

ClinicalTrials.gov

This is a registry record for a planned interventional study with no results posted; enrollment has not yet begun, making it a feasibility and safety assessment in an understudied population.

AUG 12, 2026 · PHASE 2 TRIAL

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

ClinicalTrials.gov

Early-phase interventional study (Phase 2) with small planned enrollment (n=20) assessing feasibility and safety of a novel psychedelic intervention in a specific population; results not yet reported.

AUG 12, 2026 · PHASE 2 TRIAL

Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

ClinicalTrials.gov

This is an active Phase 2 trial registration with no results yet posted; it describes a planned study of feasibility and safety in a small cohort.